英文别名KO-539; KO 539; KO539; Komzifti; ziftomenibum; 4-methyl-5-[[4-[[2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]piperidin-1-yl]methyl]-1-[(2S)-2-(4-methylsulfonylpiperazin-1-yl)propyl]indole-2-carbonitrile; (S)-4-Methyl-5-((4-((2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)methyl)-1-(2-(4-(methylsulfonyl)piperazin-1-yl)propyl)-1H-indole-2-carbonitrile; Menin-Mixed Lineage Leukemia Protein-Protein Interaction Inhibitor KO 539; Menin-MLL Inhibitor KO-539; Menin-KMT2A Inhibitor KO 539; Menin-mll interaction inhibitor KO 539 
